You are here

Article Text

Article menu
Download PDFPDF
PostScript
Correspondence
The Authors' reply
  1. Maureen Watt1,
  2. Stuart Mealing1,
  3. Mealing Eaton1,
  4. Mark Sculpher1,
  5. Pascale Brasseur2,
  6. Rachele Busca2,
  7. Nicolo Piazza3,
  8. Stephen Palmer4,
  9. Neil Moat5
  1. 1Health Economics, Oxford Outcomes Ltd, Oxford, UK
  2. 2Reimbursement CardioVascular Europe, Medtronic International Trading Sarl, Tolochenaz, Switzerland
  3. 3Cardiovascular Surgery, Munich Heart Centre, Munich, Germany
  4. 4Centre for Health Economics, University of York, York, USA
  5. 5Department of Cardiac Surgery, Royal Brompton Hospital, London, UK
  1. Correspondence to Ms Maureen Watt, Health Economics, Oxford Outcomes Ltd, Seacourt Tower, West Way, Botley, Oxford OX2 0JJ, UK; mozzawatt{at}gmail.com

https://doi.org/10.1136/heartjnl-2012-302273

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    The Authors' reply: Van Baal argues that we have under-estimated the cost associated with transcatheter aortic valve implantation (TAVI) and as a result, we have generated an overly-optimistic picture of its cost effectiveness. …

    View Full Text

    Footnotes

    • Linked article 302272.

    • Funding This study was supported by Medtronic International Trading.

    • Competing interests None.

    • Provenance and peer review Commissioned; internally peer reviewed.

    Linked Articles